Options Medical Weight Loss Clinic

Options Medical Weight Loss Clinic operates multiple locations throughout Chicago, IL, delivering physician-supervised weight loss programs that combine prescription medication management with structured nutritional guidance and behavioral coaching. Under the leadership of CEO Jeremy Castle, the clinic has built a reputation for evidence-based weight management protocols that address both metabolic dysfunction and hormonal imbalances contributing to weight gain. The clinic holds LegitScript certification, demonstrating compliance with healthcare standards for telemedicine and controlled substance prescribing, which is particularly relevant for patients seeking prescription weight loss medications through both in-person and virtual care models.

The clinic's primary pharmaceutical intervention centers on tirzepatide, a dual GIP/GLP-1 receptor agonist approved for chronic weight management in adults with obesity or overweight with weight-related comorbidities. Tirzepatide therapy at Options Medical Weight Loss is administered through weekly subcutaneous injections, with dosing titrated according to individual patient response and tolerance. The medication works by enhancing insulin secretion, suppressing glucagon release, and slowing gastric emptying, which collectively reduce appetite and caloric intake. Patients typically begin at a low dose with gradual increases over several months to minimize gastrointestinal side effects. Beyond tirzepatide, the clinic incorporates hormone therapy services to address thyroid dysfunction, testosterone deficiency, and estrogen imbalances that can impede weight loss efforts, particularly in patients over 40 experiencing age-related metabolic decline.

The medical team at Options Medical Weight Loss includes licensed physicians who conduct initial consultations, order baseline laboratory work including metabolic panels and hormone assays, and provide ongoing medication management throughout treatment. Patients receive individualized meal planning based on macronutrient targets appropriate for their metabolic rate and weight loss goals, along with access to health coaches who provide accountability through regular check-ins. The Chicago-based clinic model emphasizes frequent touchpoints during the initial treatment phase, with patients typically seen every two to four weeks for weight tracking, side effect monitoring, and protocol adjustments. This structured oversight distinguishes the program from direct-to-consumer telemedicine models that may offer less frequent clinical interaction.

Patients beginning treatment at Options Medical Weight Loss can expect an initial consultation that includes medical history review, current medication assessment, and discussion of weight loss goals and previous attempts. Laboratory testing is ordered to establish baseline kidney function, liver enzymes, and thyroid status before initiating tirzepatide, as the medication requires monitoring in patients with renal impairment or history of pancreatitis. The clinic provides injection training for patients administering tirzepatide at home, along with detailed instructions on proper storage and disposal of injection pens. Nutritional counseling sessions focus on sustainable dietary modifications rather than restrictive meal replacement protocols, with emphasis on protein intake preservation during caloric deficit to maintain lean muscle mass. Patients are educated on expected timelines for weight reduction, typically seeing initial results within the first month of tirzepatide therapy, with continued loss over six to twelve months depending on adherence and starting BMI.

Options Medical Weight Loss serves Illinois residents through both its Chicago clinic locations and telehealth appointments for established patients or those unable to travel for in-person visits. The hybrid care model allows initial consultations and periodic in-person assessments while maintaining continuity through virtual follow-ups, which is particularly valuable for working professionals managing treatment around demanding schedules. The clinic's LegitScript certification enables compliant prescribing and medication fulfillment for Illinois patients receiving care via telemedicine, with prescriptions sent to partnered pharmacies experienced in handling GLP-1 medications that require specific storage conditions. This combination of accessibility, medical oversight, and evidence-based pharmacotherapy has contributed to the clinic's 4.7-star rating across more than 500 Google reviews, reflecting patient satisfaction with both clinical outcomes and the structured support system provided throughout the weight loss process.